Vascular disorders preceding diagnosis of cancer: Distinguishing the causal relationship based on Bradford-Hill guidelines

Angiology

Volumn 54, Issue 1, 2003, Pages 11-17

  Naschitz, Jochanan E ^a,c   Kovaleva, Julia ^a   Shaviv, Naomi ^a   Rennert, Gad ^b   Yeshurun, Daniel ^a  

^a CARMEL MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY THROMBOSIS; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; HUMAN; MEDICAL LITERATURE; MOLECULAR RECOGNITION; PARANEOPLASTIC SYNDROME; PATHOGENESIS; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR DISEASE; VASCULITIS;

EID: 0037274543     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970305400102     Document Type: Article

References (45)

1. Trousseau A: Phlegmasia alba dolens. Clinique Medicale de l'Hotel-Dieu de Paris, vol 3. London: New Sydenham Society, 1865, pp 695-727.
2. Sack GH Jr, Levin J, Bell WR: Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 56:1-37, 1977.
3. Rickles FR, Edward RL, Barb C, et al: Abnormalities of blood coagulation in patients with cancer. Cancer 51:301-307, 1983.
4. Bell WR, Starksen NF, Portfield JK: Trousseau's syndrome: Devastating coagulopathy in the absence of heparin. Am J Med 79:423-430, 1985.
5. Naschitz JE, Schechter L, Chang JB: Intermittent claudication associated with cancer - case studies. Angiology 9:696-704, 1987.
6. Naschitz JE, Yeshurun D, Abrahamson J, et al: Ischemic heart disease precipitated by occult cancer. Cancer 69:2712-2720, 1992.
7. Greer JM, Longley S, Edwards NL, et al: Vasculitis associated with malignancy: Experience with 13 patients and literature review. Medicine 67:222-230, 1988.
8. Gordon LI, Kwaan HC: Cancer- and drug-associated thrombotic thrombocytic purpura and hemolytic uremic syndrome. Semin Hematol 34:140-147, 1997.
9. Lichtman MA, Rowe JM: Hyperleukocytic leukemias: Rheological, clinical and therapeutic considerations. Blood 60:279-283, 1982.
10. Bunn PA Jr: Paraneoplastic syndromes. In: Cancer: Principles and Practice of Oncology, ed. by DeVita VT Jr, Hellman S, Rosenberg SA. Philadelphia: JB Lippincott, 1982, pp 1476-1517
11. Petterson T, Pukkala E, Teppo L, et al: Increased risk of cancer in patients with SLE. Ann Rheum Dis 51:437-439, 1992.
12. Haga HJ, Eide GE, Brun J, et al: Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 20:1335-1339, 1993.
13. Koopman MMW, Beek EJR, ten Cate JW: Diagnosis of deep vein thrombosis. Progr Cardiovasc Dis 37:1-12, 1994.
14. Bona RD, Dhami MS: Thrombosis in patients with cancer. Postgrad Med 93:131-140, 1993.
15. Lopez JA, Ross RS, Fishbein MC, et al: Nonbacterial thrombotic endocarditis: A review. Am Heart J 113:773-780, 1987.
16. Nussbacher J: Migratory venous thrombosis of legs. NY State J Med 64:2166-2173, 1964.
17. Mertz LE, Conn DL: Vasculitis associated with malignancy. Curr Opinion Rheumat 4:39-46, 1992.
18. Murgo A: Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 24:161-177, 1987.
19. Argenbright L, Bartok R: Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo: The Schwartzman phenomenon revisited. J Clin Invest 89:259-272, 1992.
20. Bradford-Hill A: The environment and disease: Association or causation? Proc Roy Soc Med 58:295-300, 1965.
21. Villa AR, Kraus A, Alarcon-Segovia D: Autoimmune rheumatic diseases and cancer: Evidence of causality? In: Cancer and Autoimmunity, ed. by Shoenfeld Y, Gershwin ME. Amsterdam: Elsevier, 2000, pp 111-117.
22. Spitzer WO: Bias versus causality: Interpreting recent evidence of oral contraceptive studies. Am J Obstet Gynecol 179(3 pt 2):S43-50, 1998.
23. Aderka D, Brown A, Zelikovski A, et al: Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 57:1846-1849, 1986.
24. Monreal M, Lafoz E, Casals A, et al: Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 67:541-545, 1991.
25. Prandoni P, Lensing AWA, Buller HR, et al: Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128-1233, 1992.
26. Sorensen HT, Melemkjaer L, Steffensen FH, et al: The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169-1173, 1998.
27. Baron JA, Gridley G, Weiderpass E, et al: Venous thromboembolism and cancer. Lancet 351:1077-1080, 1998.
28. Schulman S, Lindmarker P: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of anticoagulation trial. N Engl J Med 342:1953-1958, 2000.
29. Bastounis EA, Karayiannakis AJ, Makri GG, et al: The incidence of occult cancer in patients with deep venous thrombosis: A prospective study. J Intern Med 239:153-156, 1996.
30. Tatsis E, Reinhold-Keller E, Steindorf K, et al: Wegener's granulomatosis associated with renal cell carcinoma. Arthritis Rheum 42:751-756, 1999.
31. Edoute Y, Haim N, Rinkevich D, et al: Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients. Am J Med 102:252-258, 1997.
32. Reisner SA, Brenner B, Haim N, et al: Echocardiography in nonbacterial thrombotic endocarditis: From autopsy to clinical entity. J Am Soc Echocardiogr 13:876-881, 2000.
33. Lieberman JS, Borrero J, Urrdeaneta E, et al: Thrombophlebitis and cancer. 177:542-545, 1961.
34. Sanchez-Guerrero J, Gutierrez-Urena S, Vidaller A, et al: Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J Rheumatol 17:1458-1462, 1990.
35. Kurzrock R, Cohen PR: Vasculitis and cancer. Clin Dermatol 11:175-187, 1993.
36. Antman K, Skarin A, Mayer R: Microangiopathic hemolytic anemia and cancer: A review. Medicine 58:377-384, 1979.
37. Strauss RG, Ciavarella D, Gilcher RO: Special issue: Clinical applications of therapeutic hemapheresis. J Clin Apheresis 8:189-196, 1993.
38. Naschitz JE, Yeshurun D, Eldar S, et al: Diagnosis of cancer-associated vascular disorders. Cancer 77: 1759-1767, 1996.
39. Rozenbaum M, Naschitz JE, Rosner I, et al: Paraneoplastic leukocytoclastic vasculitis. Remission of protracted leukocytoclastic vasculitis after resection of pulmonary adenocarcinoma. J Clin Rheumatol 2:99-102, 1996.
40. Naschitz JE, Rosner I, Rozenbaum M, et al: Rheumatic syndromes: Clues to occult neoplasia. Semin Arthris Rheum 29:43-55, 1999.
41. Nathanson L, Hall TC: Introduction: Paraneoplastic syndromes. Semin Oncology 24:265-268, 1997.
42. Hillen HF: Thrombosis in cancer patients. Ann Oncol. 11(suppl 3):273-276, 2000.
43. Rosenberg RD, Aird WC: Vascular-bed-specific homeostasis and hypercoagulable states. N Engl J Med 340:1555-1564, 1999.
44. Naschitz JE, Yeshurun D, Lev LM: Thromboembolism in cancer. Changing trends. Cancer 71:1384-1390, 1993.
45. Sweeney DM, Manzi S, Janosky J, et al: Risk of malignancy in women with SLE. Rheumatol 22:1478-1482, 1995.